1-4 of 4
Don L. Gibbons, M.D., Ph.D.
Close
Sort by
Journal Articles

Mutational Analysis of Chronic Phase Chronic Myeloid Leukemia (CMLCP) Clones Reveals Heightened BCR-ABL1 Genetic Instability in Patients Failing Sequential Imatinib and Dasatinib Therapy.

Alfonso QuintasCardama, MD, Don L. Gibbons, M.D., Ph.D., Hagop M. Kantarjian, MD, Moshe Talpaz, Nicholas Donato, PhD, Jorge Cortes, MD
Journal: Blood
Blood (2008) 112 (11): 2114.
https://doi.org/10.1182/blood.V112.11.2114.2114
Published: 2008
Journal Articles

Sequencing of Subcloned PCR Products Facilitates Earlier Detection of BCR-ABL1 T315I Mutants Compared to Direct Sequencing of the ABL1 Kinase Domain.

Alfonso Quintás-Cardama, MD, Don L. Gibbons, M.D., Ph.D., Hagop Kantarjian, M.D., Moshe Talpaz, M.D., Nicholas Donato, Ph.D., Jorge Cortes, M.D.
Journal: Blood
Blood (2007) 110 (11): 1952.
https://doi.org/10.1182/blood.V110.11.1952.1952
Published: 2007
Journal Articles

Mutations within BCR-ABL1 295–312 Define a Novel Region Associated with Poor Prognosis in Patients with Chronic Myelogenous Leukemia (CML) Resistant to Imatinib.

Alfonso Quintás-Cardama, MD, Don L. Gibbons, M.D., Ph.D., Hagop Kantarjian, M.D., Moshe Talpaz, M.D., Jorge Cortes, M.D., Nicholas Donato, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1936.
https://doi.org/10.1182/blood.V110.11.1936.1936
Published: 2007
Journal Articles

Mutational Analysis of Chronic Myeloid Leukemia (CML) Clones Reveals Heightened BCR-ABL1 Genetic Instability and Wild-Type BCR-ABL1 Exhaustion in Patients Failing Sequential Imatinib and Dasatinib Therapy.

Alfonso Quintás-Cardama, MD, Don L. Gibbons, M.D., Ph.D., Hagop Kantarjian, M.D., Moshe Talpaz, M.D., Nick Donato, Ph.D., Jorge Cortes, M.D.
Journal: Blood
Blood (2007) 110 (11): 1938.
https://doi.org/10.1182/blood.V110.11.1938.1938
Published: 2007